![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hb2934contents.gif)
Acta Cryst. (2009). E65, o970-o971 [ doi:10.1107/S160053680901160X ]
Abstract: The title compound, C16H20N4O3S·0.25CH4O·0.25H2O, is a hydrate/methanol solvate of torasemide, a diuretic drug used in the treatment of hypertension. The asymmetric unit contains two torasemide molecules and half-occupied methanol and water molecules. It is isomorphous with the previously reported nonsolvated T-II form of torasemide. The water molecules contribute to the stability of the structure by participating in an extensive system of O-H
O hydrogen bonds; N-H
N and N-H
O hydrogen bonds are also present. Both asymmetric molecules of torasemide form inversion dimers in the crystal.
Online 8 April 2009
Copyright © International Union of Crystallography
IUCr Webmaster